Caignard A - Search Results

1

In vivo local expansion of clonal T cell subpopulations in renal cell carcinoma.

Gaudin C, Dietrich PY, Robache S, Guillard M, Escudier B, Lacombe MJ, Kumar A, Triebel F, Caignard A. Gaudin C, et al. Among authors: caignard a. Cancer Res. 1995 Feb 1;55(3):685-90. Cancer Res. 1995. PMID: 7834641

2

Analysis of T-cell-receptor variable gene segment usage in peripheral-blood lymphocytes of advanced cancer patients.

Angevin E, Farace F, Genevée C, Henry-Amar M, Caignard A, Dietrich PY, Escudier B, Hercend T, Triebel F. Angevin E, et al. Among authors: caignard a. Int J Cancer. 1993 Apr 22;54(1):60-7. doi: 10.1002/ijc.2910540111. Int J Cancer. 1993. PMID: 8478148

3

In situ demonstration of renal-cell-carcinoma-specific T-cell clones.

Caignard A, Guillard M, Gaudin C, Escudier B, Triebel F, Dietrich PY. Caignard A, et al. Int J Cancer. 1996 May 16;66(4):564-70. doi: 10.1002/(SICI)1097-0215(19960516)66:4<564::AID-IJC23>3.0.CO;2-6. Int J Cancer. 1996. PMID: 8635875

4

Killer inhibitory receptor (CD158b) modulates the lytic activity of tumor-specific T lymphocytes infiltrating renal cell carcinomas.

Guerra N, Guillard M, Angevin E, Echchakir H, Escudier B, Moretta A, Chouaib S, Caignard A. Guerra N, et al. Among authors: caignard a. Blood. 2000 May 1;95(9):2883-9. Blood. 2000. PMID: 10779435 Free article.

5

Tumor-specific up-regulation of the nonclassical class I HLA-G antigen expression in renal carcinoma.

Ibrahim EC, Guerra N, Lacombe MJ, Angevin E, Chouaib S, Carosella ED, Caignard A, Paul P. Ibrahim EC, et al. Among authors: caignard a. Cancer Res. 2001 Sep 15;61(18):6838-45. Cancer Res. 2001. PMID: 11559559

6

In vivo T-cell clonal amplification at time of acute graft-versus-host disease.

Dietrich PY, Caignard A, Lim A, Chung V, Pico JL, Pannetier C, Kourilsky P, Hercend T, Even J, Triebel F. Dietrich PY, et al. Among authors: caignard a. Blood. 1994 Oct 15;84(8):2815-20. Blood. 1994. PMID: 7919391 Free article.

7

Evidence for T-cell clonal expansion in a patient with squamous cell carcinoma of the head and neck.

Caignard A, Dietrich PY, Morand V, Lim A, Pannetier C, Leridant AM, Hercend T, Even J, Kourilsky P, Triebel F. Caignard A, et al. Cancer Res. 1994 Mar 1;54(5):1292-7. Cancer Res. 1994. PMID: 8118818

8

Influence of interleukin-2 administration on the expression of T-cell receptor V gene segments in patients with renal-cell carcinoma.

Farace F, Angevin E, Escudier B, Caignard A, Dietrich PY, Genevee C, Hercend T, Triebel F. Farace F, et al. Among authors: caignard a. Int J Cancer. 1993 Jul 9;54(5):741-7. doi: 10.1002/ijc.2910540506. Int J Cancer. 1993. PMID: 8325704

9

Engagement of the inhibitory receptor CD158a interrupts TCR signaling, preventing dynamic membrane reorganization in CTL/tumor cell interaction.

Guerra N, Michel F, Gati A, Gaudin C, Mishal Z, Escudier B, Acuto O, Chouaib S, Caignard A. Guerra N, et al. Among authors: caignard a. Blood. 2002 Oct 15;100(8):2874-81. doi: 10.1182/blood-2002-02-0643. Blood. 2002. PMID: 12351398 Free article.

10

CD158 receptor controls cytotoxic T-lymphocyte susceptibility to tumor-mediated activation-induced cell death by interfering with Fas signaling.

Gati A, Guerra N, Gaudin C, Da Rocha S, Escudier B, Lécluse Y, Bettaieb A, Chouaib S, Caignard A. Gati A, et al. Among authors: caignard a. Cancer Res. 2003 Nov 1;63(21):7475-82. Cancer Res. 2003. PMID: 14612548

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

130 results

Search Page

Filters